Michael F Clarke

This inventor holds 34 USPTO granted patents and 21 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Cancer Stem Cells. Top assignees: University of Michigan, Leland Stanford Junior University, Oncomed Pharmaceuticals, Inc.. Active years: 1995-2025.

USPTO Granted Patents = 34 (Patent Applications = 21)

% Patents Active = 55.9

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 3.3

ph-index = 19

Forward Citations = 1,612(Granted Patents)

Location History:

Ann Arbor, MI (US) (1995 - 2016)
Menlo Park, CA (US) (2011 - 2017)
Palo Alto, CA (US) (2010 - 2019)
San Francisco, CA (US) (2022)
Stanford, CA (US) (2017 - 2024)

Company Filing History:

27 out of 3,525

University of Michigan

patents

7 out of 5,509

Leland Stanford Junior University

patents

3 out of 94

Oncomed Pharmaceuticals, Inc.

patents

4. 1 out of 4

Chan Zuckerberg Biohub, Inc.

where one patent can have more than one assignee

Years Active: 1995-2025

Loading Chart...

Areas of Expertise:

Single Cell Analysis

Cancer Treatment

Stem Cell Isolation

Notch4 Antagonist

Tumor Stem Cells

Bone Morphogenic Factor

Triple-Negative Breast Cancer

Pancreatic Cancer

Gene Expression

Chromatin Modifiers

Hematopoietic Cells

Cell Population Analysis

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12460260 - Methods utilizing single cell genetic data for cell population analysis and applications thereof (2025-11-04),

2. 12012599 - Compositions and methods for modulating left-right differentiation factor (LEFTY) and bone morphogenic factor (BMP) (2024-06-18),

3. 11471477 - Methods for treating triple-negative breast cancer (2022-10-18),

4. 10227567 - Isolation and use of solid tumor stem cells (2019-03-12),

5. 9850483 - Methods and systems for analysis of single cells (2017-12-26),

6. 9752150 - Targeting chromatin modifiers for the treatment of medical conditions (2017-09-05),

7. 9492538 - Isolation and use of solid tumor stem cells (2016-11-15),

8. 9329170 - Single cell gene expression for diagnosis, prognosis and identification of drug targets (2016-05-03),

9. 9089556 - Method for treating cancer using an antibody that inhibits notch4 signaling (2015-07-28),

10. 8765390 - Identification and isolation of squamous carcinoma stem cells (2014-07-01),

11. 8501472 - Compositions and methods for treating and diagnosing pancreatic cancer (2013-08-06),

12. 8420885 - Determining the capability of a test compound to affect solid tumor stem cells (2013-04-16),

13. 8357491 - Isolation and use of solid tumor stem cells (2013-01-22),

14. 8148147 - Compositions and methods for treating and diagnosing pancreatic cancer (2012-04-03),

15. 8044259 - Determining the capability of a test compound to affect solid tumor stem cells (2011-10-25),

Title: The Innovative Journey of Michael F Clarke

Introduction: Michael F Clarke, a talented inventor based in Palo Alto, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Michael F Clarke's latest patents include cutting-edge technologies in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With over two decades of experience in the tech industry, Michael F Clarke has a proven track record of turning innovative ideas into successful products. His ability to blend creativity with technical expertise has led to the development of revolutionary solutions that have shaped the industry.

Collaborations: Throughout his career, Michael F Clarke has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His collaborative spirit and passion for innovation have resulted in fruitful partnerships that have accelerated the pace of technological advancement.

Conclusion: Michael F Clarke's dedication to pushing the boundaries of innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventive spirit continues to inspire the next generation of inventors and shape the future of technology.